Teleflex Incorporated (NYSE:TFX) Stock Position Reduced by Mercer Global Advisors Inc. ADV

Mercer Global Advisors Inc. ADV decreased its stake in Teleflex Incorporated (NYSE:TFX) by 30.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,279 shares of the medical technology company’s stock after selling 976 shares during the quarter. Mercer Global Advisors Inc. ADV’s holdings in Teleflex were worth $406,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of TFX. Barclays PLC raised its holdings in shares of Teleflex by 1.6% during the third quarter. Barclays PLC now owns 89,907 shares of the medical technology company’s stock worth $22,233,000 after acquiring an additional 1,426 shares in the last quarter. Franklin Resources Inc. increased its position in Teleflex by 64.3% in the 3rd quarter. Franklin Resources Inc. now owns 9,683 shares of the medical technology company’s stock worth $2,298,000 after purchasing an additional 3,790 shares during the last quarter. Principal Financial Group Inc. increased its position in Teleflex by 2.7% in the 3rd quarter. Principal Financial Group Inc. now owns 80,409 shares of the medical technology company’s stock worth $19,887,000 after purchasing an additional 2,086 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in shares of Teleflex by 4.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,305 shares of the medical technology company’s stock worth $588,000 after purchasing an additional 128 shares in the last quarter. Finally, Czech National Bank lifted its holdings in shares of Teleflex by 4.9% during the 4th quarter. Czech National Bank now owns 10,070 shares of the medical technology company’s stock valued at $1,792,000 after buying an additional 472 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on TFX shares. Citizens Jmp downgraded Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Truist Financial cut their price target on shares of Teleflex from $140.00 to $137.00 and set a “hold” rating on the stock in a report on Monday, May 5th. Royal Bank of Canada decreased their price objective on shares of Teleflex from $150.00 to $145.00 and set a “sector perform” rating for the company in a report on Friday, May 2nd. Bank of America downgraded shares of Teleflex from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. Finally, Mizuho set a $155.00 price target on Teleflex in a research report on Wednesday, April 16th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $164.63.

Teleflex Stock Down 1.8%

Teleflex stock opened at $126.93 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a fifty-two week low of $120.06 and a fifty-two week high of $249.91. The firm has a fifty day moving average price of $133.57 and a two-hundred day moving average price of $164.91. The firm has a market cap of $5.61 billion, a price-to-earnings ratio of 25.23, a P/E/G ratio of 1.73 and a beta of 1.17.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.88 by $0.03. The firm had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm’s revenue for the quarter was down 5.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.21 EPS. As a group, analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th will be given a $0.34 dividend. The ex-dividend date is Tuesday, May 20th. This represents a $1.36 annualized dividend and a dividend yield of 1.07%. Teleflex’s dividend payout ratio is 42.90%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.